Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NN5F
|
||||
Former ID |
DIB009360
|
||||
Drug Name |
BChE inhibitors
|
||||
Synonyms |
BChE inhibitors (imaging, Alzheimers disease); BChE inhibitors (imaging, Alzheimers disease), University ofNebraska Medical Center; Imaging/therapeutic butyrylcholinesterase inhibitors (Alzheimers disease), UNMC
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Investigative | [552019] | ||
Company |
University of Nebraska Medical Center
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[nH]1c(=O)n(cc(c1=O)C)[C@H]1C[C@@H]([C@H](O1)COP1(=O)Oc<br />2c(cc(c(c2CO1)F)C(C)(C)C)C(C)(C)C)[18F]
|
||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [543635] | |
WikiPathways | Irinotecan Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.